Clinical Clarity

One Molecule at a Time

Single Molecule Counting (SMC™) from Singulex is transforming clinical diagnostics and scientific discovery.

Learn More

Clinical Lab Testing Services
Clinical Diagnostics System

Singulex is the developer and leading provider of single molecule counting (SMCTM) technology for clinical diagnostics and scientific discovery. Singulex's proprietary SMC technology enables physicians and scientists to detect biomarkers of disease that were previously undetectable. Powered by SMC technology, Singulex's ultra-sensitive immunoassay solutions and lab testing services are transforming patient care from reactive disease treatment to proactive health management and fueling the discovery and development of new therapeutics.

Press Releases

  • August 27, 2014
    Singulex Announces Preview of the Sgx ClarityTM IVD System and Presentation of 10 Abstracts Demonstrating Single Molecule (SMCTM) Technology Performance in Cardiovascular Disease at 2014 ESC Congress
  • July 23, 2014
    Singulex Highlights Development Progress With Ultrasensitive Sgx ClarityTM System at AACC 2014

Upcoming Events

  • Jul 31, 2013 - Jul 31, 2015:
    Ultrasensitive Immunoassays for Translation of Biomarkers from Discovery to the Clinic
    On Demand
  • Aug 30, 2014 - Sep 3, 2014:
    ESC Congress
    Fira Gran Via Barcelona, Spain